Evidence map›Paper›PMID 38665880›Full record

Article3 Biotech2024

Structure-based virtual screening of mangiferin derivatives with antidiabetic action: a molecular docking and dynamics study and MPO-based drug-likeness approach.

Francisco Flávio da Silva Lopes, Francisco Nithael Melo Lúcio, Matheus Nunes da Rocha, Victor Moreira de Oliveira, Caio Henrique Alexandre Roberto, Márcia Machado Marinho, Emmanuel Silva Marinho, Selene Maia de Morais

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Coumarin benzamide scaffold as potential 5-HTJournal of molecular modeling · 2025
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Francisco Flávio da Silva LopesDoctoral Program in Biotechnology, Northeast Biotechnology Network, State University of Ceará, Fortaleza, CE Brazil.
Francisco Nithael Melo LúcioDoctoral Program in Biotechnology, Northeast Biotechnology Network, State University of Ceará, Fortaleza, CE Brazil.
Matheus Nunes da RochaPostgraduate Program in Natural Sciences, State University of Ceará, Fortaleza, CE Brazil.
Victor Moreira de OliveiraPostgraduate Program in Natural Sciences, State University of Ceará, Fortaleza, CE Brazil.
Caio Henrique Alexandre RobertoPostgraduate Program in Natural Sciences, State University of Ceará, Fortaleza, CE Brazil.
Márcia Machado MarinhoScience and Technology Centre, Course of Chemistry, State University Vale do Acaraú, Sobral, CE Brazil.
Emmanuel Silva MarinhoPostgraduate Program in Natural Sciences, State University of Ceará, Fortaleza, CE Brazil.
Selene Maia de MoraisDoctoral Program in Biotechnology, Northeast Biotechnology Network, State University of Ceará, Fortaleza, CE Brazil.ORCID 0000-0002-2766-3790
Universidade Estadual do Ceará · BRState University of Vale do Acaraú · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracts from Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-03978-9.

Indexed as

AntidiabeticDrug-likenessDynamicsMangiferin derivativesMolecular docking

Identifiers

PMID38665880
PMCPMC11039600
OpenAlexW4395039888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.